Solvay S.A.

Solvay S.A.

SVYSF
Solvay S.A.US flagOther OTC
32.50
USD
- -
- -
3.40BMarket Cap
Solvay S.A.
SVYSF
(Other OTC)

Recent

price

32.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
68.87
87.51
124.58
114.71
127.71
120.4
97.24
106.28
109.41
108.81
94.18
110.45
76.9
57.84
48.86
45.43
44.45
Revenue per Share
21.07
2.86
6.43
3.05
0.96
4.85
6.01
10.27
8.49
1.14
-9.33
9.16
18.36
20.09
2.12
0.29
-0.25
Basic EPS, GAAP
3.52
2.87
16.64
4.88
7.62
3.01
7.81
7.43
8.59
9.29
6.85
8.34
10.57
8.13
3.14
4.42
4.25
Free Cash Flow per Basic Share
2.87
3.08
3.17
3.88
3.5
3.86
3.74
3.83
3.98
4.13
4.06
4.16
4.02
4.07
2.48
2.5
2.43
Dividend per Share
14.69
14.71
82.99
82.01
84.39
87.27
72.48
77.81
81.55
78.02
63.73
68.15
81.37
18.43
18.57
16.57
2.27
Book Value per Share
75.46
26.75
27.34
30.92
25.03
-1.09
6.56
17.15
25.1
24.38
18.38
32.53
49.58
3.27
3.85
1.22
2.07
Tangible Book Value per Share
87
86
88
88
83
84
103
103
103
103
103
104
104
104
105
104
104
Basic Weighted Avg Shares
5,959
7,563
10,910
10,149
10,629
10,082
10,044
10,984
11,299
11,227
9,714
11,435
7,978
6,025
5,130
4,746
4,645
Sales/Revenue/Turnover
9.58
7.19
8.02
7.01
8.98
8.67
9.51
10.39
10.78
10.57
8.69
10.59
10.05
13.59
12.69
10.03
9.54
Operating Margin (%)
607
455
794
872
1,430
783
1,025
1,152
921
1,032
2,416
849
923
994
362
404
404
Depreciation Expense
1,823
247
563
270
80
406
621
1,061
877
118
-962
948
1,905
2,093
223
30
-26
Net Income, GAAP
- -
6.03
29.39
44.97
24.49
14.62
- -
- -
9.48
206.76
- -
10.05
20.14
115.56
27.19
76.43
123.81
Effective Tax Rate (%)
30.59
3.27
5.16
2.66
0.75
4.03
6.18
9.66
7.76
1.05
-9.9
8.29
23.88
34.74
4.35
0.63
-0.56
Profit Margin (%)
6,310
2,758
3,198
3,162
1,336
2,282
1,596
1,929
2,672
2,181
1,709
1,302
2,125
522
563
311
404
Working Capital
2,535
3,374
3,321
2,809
1,485
5,628
4,087
2,900
2,971
3,227
3,117
2,520
2,407
243
1,728
1,800
1,830
LT Debt
6,708
6,648
6,573
7,452
6,778
9,668
9,957
9,754
10,626
9,624
7,303
8,851
10,664
1,306
1,404
1,082
1,181
Total Equity
- -
5.03
5.85
3.66
6.98
5.77
- -
- -
7.79
-8.88
- -
9.38
4.93
-1.66
18.5
3.33
-2.96
Return on Invested Capital (%)
- -
7.72
9.31
3.35
3.69
4.31
- -
- -
8.49
-1.51
- -
9.77
17.56
29.93
9.68
1.34
-2.51
Return on Capital (%)
143.43
19.43
13.19
3.72
1.12
5.67
8.39
13.66
10.65
1.43
-13.16
13.91
24.59
40.4
11.52
1.63
-10.97
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
161
331
366
LT Borrowings
2,047
1,494
1,830
LT Finance Leases
- -
306
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
104
104
104
Market Capitalization
2,761
2,831
2,619

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
2,201
2,156
2,190
Cash, Cash Equivalents & STI
426
555
501
Accounts Receivable, Net
703
622
678
Inventories
578
587
592
Total Current Liabilities
1,558
1,845
1,786
Payables & Accruals
- -
- -
- -
ST Debt
161
331
366
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-8.52%
-12.3%
-22.93%
Free Cash Flow
21.8%
1.07%
40%
Net Income, GAAP
-115.9%
-52.72%
-86.55%
Sales/Revenue/Turnover
-6.16%
-11.87%
-7.49%
Total Cash Common Dividend
-0.91%
-7.4%
0.38%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,298
1,333
1,245
1,254
5,130
2025
1,243
1,212
1,196
1,095
4,746
2026
1,142
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.02
0.64
0.18
0.29
2.12
2025
0.78
0.09
0.33
-0.91
0.29
2026
0.25
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.62
0.82
- -
- -
2.48
2025
0.97
1.46
- -
- -
2.5
2026
0.97
- -
- -
- -
- -
Business
Solvay SA engages in the production and sale of essential chemicals worldwide, focusing on basic and performance chemicals for resilient markets including consumer goods, healthcare, food, electronics, building and construction, automotive, and resources. The company offers soda ash and derivatives such as sodium bicarbonate and calcium chloride; hydrogen peroxide and peroxides; silica including highly dispersible silica; specialty chemicals; and products from Coatis such as guar derivatives and surfactants, marketed through over 1,000 product lines with safety data sheets in 39 languages. Founded in 1863 and headquartered in Neder-Over-Heembeek, Brussels, Belgium, Solvay operates approximately 45 industrial sites and 12 R&I centers across 41 countries in Europe, North America, Asia, Latin America, and other regions, employing over 9,000 people following its 2023 demerger that created Syensqo for specialty chemicals. Recent developments include signing two supply contracts in November 2025 with U.S. magnet manufacturers Permag and LCM for rare earths like NdPr and DyTb to bolster secure supply chains; a ten-year agreement with Sapio for Europe's first renewable hydrogen production hub by mid-2026; advancement of the For Generations sustainability roadmap targeting carbon neutrality by 2050 with 30% Scope 1 and 2 emissions reduction by 2030; ongoing operational transformation yielding €110 million in cost savings by end-2024 toward a €200 million target; expansion of recycling capacities at sites like Livorno, Italy for circular silica; completion of a share buyback program in October 2024; and strong 2024 financials with €4.7-4.88 billion in revenues and €1.246 billion underlying EBITDA despite market challenges.

Company News

APIChat
  • Solvay SA (SLVYY) Q1 2026 Earnings Call Transcript

  • Short Interest in Solvay SA (OTCMKTS:SVYSF) Grows By 79.3%